Micronised Resveratrol as a Treatment for Friedreich Ataxia

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 23, 2019

Primary Completion Date

March 28, 2024

Study Completion Date

March 28, 2024

Conditions
Friedreich Ataxia
Interventions
DRUG

Resveratrol

Drug name: Micronised resveratrol. Dosage form: 500mg capsules. Alternate name: 1,3-Benzenediol, 5-\[2-(4-hydroxyphenyl)ethenyl\]-, (E). Ingredients: 99.50% pure trans-resveratrol. Placebo capsules will be identical in terms of taste, smell, and appearance.

Trial Locations (4)

2065

Royal North Shore Hospital, St Leonards

3052

Murdoch Children's Research Institute, Parkville

4029

University of Queensland Centre for Clinical Research, Herston

6000

Royal Perth Hospital, Perth

All Listed Sponsors
lead

Murdoch Childrens Research Institute

OTHER

NCT03933163 - Micronised Resveratrol as a Treatment for Friedreich Ataxia | Biotech Hunter | Biotech Hunter